| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2141.1971.TB03413.X |
| P698 | PubMed publication ID | 5559480 |
| P2093 | author name string | J Newman | |
| A J Johnson | |||
| S Puszkin | |||
| M H Karpatkin | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1-20 | |
| P577 | publication date | 1971-07-01 | |
| P1433 | published in | British Journal of Haematology | Q4970200 |
| P1476 | title | Methods for the production of clinically effective intermediate- and high-purity factor-VIII concentrates | |
| P478 | volume | 21 |
| Q45878671 | A Method for Detecting Factor-VIII Clotting Activity Associated with Factor VIII-related Antigen in Agarose Gels |
| Q40603799 | A Randomized Study of Factor VIII or Prothrombin Complex Concentrate Infusions in Children with Haemophilia and Antibodies to Factor VIII |
| Q34621106 | A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin |
| Q41151443 | A new simple assay for factor VIII related antigen |
| Q36254648 | Activation of factor IX bound to cultured bovine aortic endothelial cells |
| Q39393315 | Alternatives for Plasma Fractionation |
| Q39583209 | Amidase activity in FVIII concentrate associated with α2M |
| Q54629111 | An alternative method of large scale plasma fractionation for the lsolation of serum albumin |
| Q37685042 | An endothelial cell-dependent pathway of coagulation |
| Q40710616 | An optimized radioimmunoassay of F VIII related antigen (F VIIIR:AG) in plasma and eluates |
| Q33846261 | Antibody to hepatitis B surface antigen in haemophiliacs on long-term therapy with Scottish factor VIII |
| Q93735033 | Antigen-biological-activity ratio for factor VIII |
| Q33445370 | Binding of Factor VIII to Platelets in the Presence of Ristocetin |
| Q34622020 | Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation |
| Q36350530 | Cellular processing of bovine factors X and Xa by cultured bovine aortic endothelial cells |
| Q43700006 | Clinical Investigation of Intermediate- and High-Purity Antihaemophilic Factor (Factor VIII) Concentrates |
| Q43806256 | Coagulation in an Agarose Gel and its Application to the Detection and Measurement of Factor VIII Antibodies |
| Q68859445 | Comparative chromatography of plasma and plasma concentrates rich in factors VIIIand IX |
| Q40667254 | Differentiation of antihemophilic factor (AHF) and von Willebrand factor (vWF) by their interaction with urea and selected amino acids |
| Q54685308 | Dissociation of Factor VIII-related antigen into subunits |
| Q34543322 | Effects of plasmin on von Willebrand factor multimers. Degradation in vitro and stimulation of release in vivo |
| Q36209412 | Electron microscopy of human factor VIII/Von Willebrand glycoprotein: effect of reducing reagents on structure and function |
| Q40716692 | Enhanced Yield of Antihemophilic Factor and von Willebrand Factor by Cryoprecipitation with Polyethylene Glycol |
| Q34560030 | Epitope mapping of the von Willebrand factor subunit distinguishes fragments present in normal and type IIA von Willebrand disease from those generated by plasmin |
| Q69118819 | Experimental Model for von Willebrand's Disease |
| Q69558397 | Freezing Plasma in 5-Litre Bags for Storage and Thawing for Use |
| Q45856279 | Gm Types and Antibodies in Multitransfused Haemophiliacs |
| Q55055695 | Haemophilia A and the blood transfusion service: a Scottish study |
| Q34189598 | Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo |
| Q41714134 | Improved Yields of Factor VIII from Heparinized Plasma |
| Q34565552 | Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody |
| Q34624945 | Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation |
| Q37554183 | Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation |
| Q67291452 | Large-scale purification of factor VIII by affinity chromatography: optimization of process parameters |
| Q40561391 | Maxillo-facial injury in severe haemophilia |
| Q34889432 | Molecular structural studies of human factor VIII |
| Q59071617 | Molecular weights of antihaemophilic factor and von Willebrand factor proteins in human plasma |
| Q33821754 | Platelets have more than one binding site for von Willebrand factor |
| Q68379181 | Polypeptide fraction from bovine factor VIII does not influence human platelet aggregation and blood coagulation |
| Q33481601 | Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent |
| Q54381625 | Properties of post-infusion factor VIII in Von Willebrand's disease |
| Q35033733 | Recent Advances in Haemophilia and Von Willebrand's Disease |
| Q40651808 | Relationship of sialic acid to function and in vivo survival of human factor VIII/von Willebrand factor protein |
| Q70927614 | Removal of Polyethylene Glycol from Proteins by Salt‐Induced Phase Separation |
| Q35228208 | Report of a clinical trial of a Canadian preparation of antihemophilic factor |
| Q35354493 | Safety aspects in the manufacturing of plasma-derived coagulation factor concentrates |
| Q39961071 | Sodium Periodate Modification of Factor VIII Procoagulant Activity |
| Q37047369 | Some Effects of Calcium on the Activation of Human Factor VIII/Von Willebrand Factor Protein by Thrombin |
| Q35199709 | Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure |
| Q39541908 | Studies on the procurement of blood coagulation factor VIII: effects of plasma freezing rate and storage conditions on cryoprecipitate quality |
| Q42015255 | Studies on the structure and subunit composition of human antihaemophilic factor |
| Q45856592 | The Absorption of Human Factor VIII Neutralizing Antibody by Factor VIII |
| Q40939286 | The effect of reducing agents on factor VIII and other coagulation factors |
| Q35899324 | The subunit structure of normal and hemophilic factor VIII |
| Q45855850 | Transfusion and Gel Filtration Studies in von Willebrand's Disease |
| Q47949876 | Use of Frozen Cryoprecipitate for the Preparation of Clinical Factor VIII Concentrate |
| Q33478102 | von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease |
| Q40916705 | “Variants” of von Willebrand's disease. Demonstration of a decreased antigenic reactivity by immunoradiometric assay |
Search more.